Keywords: eu, approval, delay, pfizer, zeldox, drug, major

EU approval delay for Pfizer's Zeldox

Article | 28 December 2000

Print This

US drug major Pfizer has said that European Union approval of itsZeldox(ziprasidone HCl) schizophrenia treatment has been delayed because ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in